Tech Company Financing Transactions
Ankasa Regenerative Therapeutics Funding Round
Ankasa Regenerative Therapeutics, operating out of La Jolla, secured $8.5 million in investment from Avalon Ventures, Correlation Ventures and Heraeus Medical.
Transaction Overview
Company Name
Announced On
6/23/2015
Transaction Type
Venture Equity
Amount
$8,500,000
Round
Series A
Investors
Proceeds Purpose
Ankasa intends to initially develop a proprietary localized therapy involving WNT3A for spinal fusion surgery patients.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
La Jolla, CA 92037
USA
La Jolla, CA 92037
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
Pharmaceutical preparations including reactivated stem cells for organ and tissue re-growth, tissue repair, and healing.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sanford Madigan
Co-Founder
Scott Burkette
Browse more venture capital transactions:
Prev: 6/23/2015: Casper Sleep venture capital transaction
Next: 6/23/2015: Sano venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs